Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Mucus: Fighting the war against pollutants

March 30, 2011 5:35 am | by EurekAlert | News | Comments

(American Friends of Tel Aviv University) New Tel Aviv University research has found that mucus, which was thought to protect our bodies against harmful pollutants, in fact may leave our bodies more vulnerable to them. But the discovery may prove useful in enabling some drugs to enter...

Biodel Announces Appointment of Dr. Brian J.G. Pereira as Board Chairman; Dr. Charles A. Sanders to Remain on Board

March 30, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

DANBURY, Conn., March 30, 2011 /- Biodel Inc. (Nasdaq: BIOD ) announced today the appointment of Dr. Brian J.G. Pereira as board chairman effective immediately.  Dr. Pereira has served on the board since November 2007.  Dr. Charles A. Sanders, who served as chairman since March...

Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes

March 30, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., March 30, 2011 /- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that screening has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD with pegylated...

Advertisement

Rx-webmasters.com is Your Number One Choice for Affordable Medications

March 30, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

LONG ISLAND CITY, N.Y., March 30, 2011 /- Everyone knows where to look for the medications that you might have a need for one day. Online pharma shops have proven to be a reliable source for medication but how can you be sure that you are buying from the right generic Viagra merchant?...

Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease

March 30, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

OSAKA, Japan and NEW YORK, March 30, 2011 /- Dainippon Sumitomo Pharma Co, Ltd. (DSP) and Intercept Pharmaceuticals, Inc. (Intercept) today announced that they have entered into an exclusive licensing agreement for the development and commercialization of Intercept's first-in-class FXR...

Winner Medical CEO Awarded and Appointed Position by CNITA

March 30, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, March 30, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical") a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced that Mr....

Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting

March 30, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., March 30, 2011 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced the schedule of its upcoming cenderitide presentation taking place at the American College of Cardiology...

Isis Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference

March 30, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., March 30, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Needham's 10th Annual Healthcare Conference on Wednesday, April 06, 2011 at 10:40 a.m. ET at the New...

Advertisement

Silence Therapeutics' Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting

March 29, 2011 10:33 pm | by Bio-Medicine.Org | News | Comments

LONDON, March 30, 2011 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") a leading global RNA interference (RNAi) therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have...

<i>Patent Watch: </i>Gene patents flow into New England

March 29, 2011 8:34 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Suffolk Law School professor Kirk Teska: Gene patents are back in the news, so let's take a look at several gene related patents and published patent applications naming New England inventors of the last year.

Covidien Announces New Data on Minimally Invasive Surgical Tools to be Presented at SAGES 2011

March 29, 2011 4:38 pm | by Covidien | News | Comments

Highlights include interim results of studies of SILS(TM) and bariatric surgery NORTH HAVEN, Conn., Mar 29, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, announced that new data on its laparoscopic surgical products will be presented at...

MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems

March 29, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., March 29, 2011 /- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent...

GSK and Valeant Receive European Authorisation for Trobalt (retigabine)

March 29, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

LONDON and MISSISSAUGA, Ontario, March 29, 2011 /- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced today that the European Commission has granted marketing authorisation for Trobalt™ (retigabine) as an adjunctive (add-on)...

Advertisement

Promidian Survey Finds Growing Support for Patient-Centered Medical Home

March 29, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

BERKELEY HEIGHTS, N.J., March 29, 2011 /- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric...

Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research

March 29, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, March 29, 2011 /- The Newborn Possibilities Fund , a grantmaking program established by Cord Blood Registry (CBR), today announced it will provide its first-ever grant to the Georgia Health Sciences University Foundation.  The university's medical center is conducting...

Important Drug Information Notice Regarding Potassium Phosphates Injection, USP, 3 mM/mL Phosphorous; 4. 4 mEq/mL Potassium: 5 mL, 15 mL and 50 mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Potassium Phosphates Injection, USP, 5mL Single Dose Vial,...

Important Drug Information Notice Regarding Sodium Thiosulfate Injection, USP, 10% (100mg/mL), 10mL Single Dose Vials and 25% (250mg/mL), 50mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Sodium Thiosulfate Injection, USP, 10%, 10mL Single Dose...

New Analysis Finds Airport Scanner Risk Extremely Low

March 29, 2011 8:33 am | by Diagnostic Imaging | News | Comments

Are airport scanners safe? In another recent analysis on the topic, researchers at the University of California have estimated the cancer risk from one kind of scanners is extremely low.

Interventional Radiologists: Y-90 Liver Cancer Treatment Effective

March 29, 2011 8:33 am | by Diagnostic Imaging | News | Comments

Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results were chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be...

MEDRAD® Announces New Head of Interventional Business

March 29, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

WARRENDALE, Pa., March 29, 2011 /- Today MEDRAD, INC. announced that Jack Darby has joined the company as vice president of MEDRAD Interventional. In his new role, Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and will...

X-Hero and Male Enhancer: Recall - Undeclared Drug Ingredient

March 29, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

Products marketed as dietary supplement contain drug ingredients sulfosildenafil or tadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

Unilife Commences Initial Production of Unifill Prefilled Syringe

March 29, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

YORK, Pa., March 29, 2011 /- Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS ; ASX: UNS) today announced it has commenced initial production of the Unifill® ready-to-fill (prefilled) syringe at its FDA-registered manufacturing facility in York, Pennsylvania. The...

Sigma-Aldrich Unveils Dynamic New Web Presence

March 29, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, March 29, 2011 /- Sigma-Aldrich Corporation (Nasdaq: SIAL ) announced the release of the first phase of its new website, www.sigma-aldrich.com . The new site has been redesigned to support and enhance scientific workflow in an effort to help researchers more easily find the...

CareFusion Completes Sale of Onsite Services Instrument Management and Repair Business

March 29, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 29, 2011 /- CareFusion (NYSE: CFN ), a leading, global medical technology company, and Frazier Healthcare today announced they have completed the sale of CareFusion's OnSite® Services instrument management and repair business to affiliates of Frazier Healthcare. The...

FDA Clears Abbott's i-STAT® 1 Wireless Point of Care Testing System

March 29, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., March 29, 2011 /- Abbott announced today it has received clearance from the U.S. Food and Drug Administration to begin marketing the i-STAT® 1 Wireless handheld, a new wireless version of the i-STAT® point of care testing system that is widely used in hospitals,...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading